Antitumor resistant anticancer drugs or radiation. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy13

Cell Line, Tumor Tumor Cells, Cultured Cell Line HT29 Cells HCT116 Cells Cells, Cultured HeLa Cells K562 Cells MCF-7 Cells HL-60 Cells KB Cells Hep G2 Cells Mitochondria

Organisms10

Mice, Nude Mice, Inbred BALB C Mice, Inbred C57BL Mice, SCID Adenoviridae Oncolytic Viruses Mice, Inbred DBA Mice, Inbred C3H Cricetinae Mice, Inbred Strains

Diseases33

Radiation Injuries Neoplasms Leukemia P388 Neoplasms, Experimental Radiation Injuries, Experimental Melanoma, Experimental Radiation Pneumonitis Sarcoma 180 Neoplasms, Radiation-Induced Breast Neoplasms Leukemia L1210 Colonic Neoplasms Lung Neoplasms Melanoma Adenocarcinoma Brain Neoplasms Fibrosarcoma Acute Radiation Syndrome Neovascularization, Pathologic Ovarian Neoplasms Sarcoma, Experimental Glioma Carcinoma, Squamous Cell Head and Neck Neoplasms Glioblastoma Mammary Neoplasms, Experimental Carcinoma, Lewis Lung Disease Models, Animal Liver Neoplasms Neoplasm Metastasis Pancreatic Neoplasms Prostatic Neoplasms Radiodermatitis

Chemicals and Drugs96

Antineoplastic Agents Antibiotics, Antineoplastic Doxorubicin Antineoplastic Agents, Phytogenic Cisplatin Drug Carriers Ellipticines Camptothecin Paclitaxel Radiation-Sensitizing Agents Etoposide P-Glycoprotein Prodrugs Enzyme Inhibitors DNA Topoisomerases, Type II Topoisomerase I Inhibitors Fluorouracil Antineoplastic Agents, Alkylating Daunorubicin DNA Plant Extracts Cancer Vaccines Antimetabolites, Antineoplastic Tumor Suppressor Protein p53 Enediynes Caspases Radiation-Protective Agents Platinum Antibodies, Monoclonal Anti-Bacterial Agents Intercalating Agents Organoplatinum Compounds Proto-Oncogene Proteins c-bcl-2 Neoplasm Proteins Angiogenesis Inhibitors Mitomycin Caspase 3 Nanocapsules Topoisomerase II Inhibitors Antigens, Neoplasm Xanthones Indoles Mitoxantrone Protein Kinase Inhibitors DNA Adducts Liposomes RNA, Messenger Bleomycin Tubulin Modulators Vinblastine RNA, Small Interfering DNA Topoisomerases, Type I Multidrug Resistance-Associated Proteins Pyrazines Cobalt Radioisotopes Amsacrine Razoxane DNA, Neoplasm Pyrimidines Deoxycytidine ATP-Binding Cassette Transporters Triazines Benzoquinones DNA-Binding Proteins Histone Deacetylase Inhibitors Boronic Acids Drugs, Investigational Reactive Oxygen Species Taxoids Depsipeptides Topotecan Thiazoles Quinazolines Teniposide Piperazines Topoisomerase Inhibitors Anticarcinogenic Agents Vincristine Naphthoquinones Recombinant Proteins Polyethylene Glycols Adjuvants, Pharmaceutic Dacarbazine Poly(ADP-ribose) Polymerases Immunotoxins Coordination Complexes Triterpenes Protein-Serine-Threonine Kinases Cyclophosphamide Sulfonamides Pyrroles Anthraquinones Macrolides Dioxoles Aziridines Vinca Alkaloids

Analytical, Diagnostic and Therapeutic Techniques and Equipment52

Radiation Dosage Drug Screening Assays, Antitumor Dose-Response Relationship, Radiation Xenograft Model Antitumor Assays Radiation Monitoring Neoplasms, Experimental Neoplasm Transplantation Drug Delivery Systems Drug Carriers Inhibitory Concentration 50 Radiation Injuries, Experimental Combined Modality Therapy Melanoma, Experimental Radiotherapy Transplantation, Heterologous Drug Design Drug Evaluation, Preclinical Radiometry Antineoplastic Combined Chemotherapy Protocols Radiotherapy Dosage Flow Cytometry Tumor Burden Blotting, Western Immunotherapy Treatment Outcome Nanocapsules Transfection Genetic Therapy Microbial Sensitivity Tests Models, Biological Molecular Targeted Therapy Drug Discovery Tumor Stem Cell Assay Sarcoma, Experimental Radiotherapy, Conformal Oncolytic Virotherapy Immunotherapy, Adoptive Radiation Hybrid Mapping Clinical Trials as Topic Mammary Neoplasms, Experimental Reverse Transcriptase Polymerase Chain Reaction Drug Administration Schedule Disease Models, Animal Dose Fractionation Models, Molecular Clinical Trials, Phase I as Topic Radiotherapy, Intensity-Modulated Brachytherapy Injections, Intralesional Lethal Dose 50 Phytotherapy Administration, Oral

Phenomena and Processes54

Radiation, Ionizing Radiation Dosage Dose-Response Relationship, Radiation Radiation Tolerance Radiation Apoptosis Drug Resistance, Neoplasm Cell Survival Cell Proliferation Drug Synergism Dose-Response Relationship, Drug Drug Resistance Gamma Rays Inhibitory Concentration 50 DNA Damage Drug Resistance, Multiple Cosmic Radiation Molecular Structure Cell Cycle Time Factors Ultraviolet Rays Background Radiation Cell Division Gene Expression Regulation, Neoplastic Signal Transduction Radiation Effects Mutation Structure-Activity Relationship DNA Repair Cell Death Transfection Drug Resistance, Microbial Base Sequence X-Rays DNA Adducts Down-Regulation Phosphorylation Cell Cycle Checkpoints Kinetics Cell Growth Processes Genetic Vectors Genes, MDR Enzyme Activation Tissue Distribution G2 Phase Gene Expression Amino Acid Sequence Phenotype Lethal Dose 50 Particle Size Up-Regulation Linear Energy Transfer Cytotoxicity, Immunologic Protein Binding

Disciplines and Occupations5

Radiation Oncology Drug Design Nanomedicine Drug Discovery Radiobiology

Technology, Industry, Agriculture5

Nanoparticles Nanocapsules Nanomedicine Liposomes Polyethylene Glycols

Information Science5

Molecular Sequence Data Base Sequence Radiotherapy, Conformal Radiotherapy, Intensity-Modulated Amino Acid Sequence

Health Care14

Radiation Dosage Radiation Injuries Dose-Response Relationship, Radiation Radiation Protection Radiation Monitoring Cosmic Radiation Radiation Injuries, Experimental Ultraviolet Rays Radiation Effects Treatment Outcome Acute Radiation Syndrome Radioactive Hazard Release Clinical Trials as Topic Clinical Trials, Phase I as Topic

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Phenomena and Processes Disciplines and Occupations Technology, Industry, Agriculture Information Science Health Care

Antineoplastic Agents Radiation, Ionizing Radiation Dosage Drug Screening Assays, Antitumor Radiation Injuries Cell Line, Tumor Dose-Response Relationship, Radiation Xenograft Model Antitumor Assays Radiation Tolerance Neoplasms Radiation Radiation Protection Antibiotics, Antineoplastic Apoptosis Radiation Monitoring Doxorubicin Drug Resistance, Neoplasm Mice, Nude Tumor Cells, Cultured Cell Survival Antineoplastic Agents, Phytogenic Cisplatin Leukemia P388 Cell Proliferation Neoplasms, Experimental Radiation Oncology Neoplasm Transplantation Drug Delivery Systems Drug Synergism Dose-Response Relationship, Drug Drug Resistance Drug Carriers Ellipticines Gamma Rays Inhibitory Concentration 50 DNA Damage Mice, Inbred BALB C Drug Resistance, Multiple Cosmic Radiation Radiation Injuries, Experimental Camptothecin Paclitaxel Radiation-Sensitizing Agents Molecular Structure Combined Modality Therapy Melanoma, Experimental Radiation Pneumonitis Cell Cycle Etoposide Sarcoma 180 P-Glycoprotein Neoplasms, Radiation-Induced Breast Neoplasms Leukemia L1210 Radiotherapy Time Factors Ultraviolet Rays Mice, Inbred C57BL Background Radiation Colonic Neoplasms Prodrugs Enzyme Inhibitors Cell Division Transplantation, Heterologous Drug Design DNA Topoisomerases, Type II Drug Evaluation, Preclinical Topoisomerase I Inhibitors Radiometry Antineoplastic Combined Chemotherapy Protocols Gene Expression Regulation, Neoplastic Radiotherapy Dosage Signal Transduction Flow Cytometry Fluorouracil Mice, SCID Radiation Effects Lung Neoplasms Cell Line Antineoplastic Agents, Alkylating Daunorubicin Tumor Burden DNA Plant Extracts Mutation Cancer Vaccines Structure-Activity Relationship Molecular Sequence Data DNA Repair Antimetabolites, Antineoplastic Melanoma Tumor Suppressor Protein p53 Enediynes Blotting, Western Nanoparticles Caspases Radiation-Protective Agents Platinum Antibodies, Monoclonal Anti-Bacterial Agents

No FAQ available that match "antitumor resistant anticancer drugs or radiation"